Altasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like
LAVAL, Québec--(BUSINESS WIRE)--#Altasciences--Altasciences is pleased to have been chosen by Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) (“Virpax”), a company specializing in developing non-addictive products for pain management, PTSD, central nervous system (CNS) disorders, and viral barrier indications, to conduct...
Source: pharmiweb.com